Héctor Pérez-montoyo
Director, Biological Research
Pharma
Ability Pharma
Spain
Biography
Héctor obtained his BSc degree in Biology in 2005 and his Ph.D. in Biology in 2010 at University of Alicante. In 2006 he moved to University of Texas Southwestern Medical Center in Dallas (EEUU), to start his career developing novel therapeutic antibodies in murine models of human autoimmune diseases and under the supervision of Dr. Sally E. Ward, a worldwide outstanding investigator in the field of autoimmune diseases and cancer.
Research Interest
During the 10 years of experience accumulated, animal research has characterized most of his work, accumulating large experience working with a large panel of murine models of different autoimmune diseases such as Multiple Sclerosis or Rheumatoid Arthritis, and in cancer, including the “Patient Derived OrthoXenograft” technique. His work always focused in understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He has collaborated in the publication of several articles in peer reviewed journals, abstracts in scientific meetings and patents.
